Bradley Herring Biography and Net Worth

CFO of Enfusion

Bradley Herring joined Enfusion as Chief Financial Officer in 2022 with more than 30 years of experience in finance leadership.

Prior to Enfusion, Herring served as Chief Financial Officer for multiple fintech companies, including Shift4 Payments, LLC, Elavon, Inc., and the digital banking group of Fiserv. Herring holds a Bachelor of Arts degree in Management and Economics and a Masters of Business Administration from Georgia Institute of Technology Scheller College of Business.

What is Bradley Herring's net worth?: The estimated net worth of Bradley Herring is at least $3.49 million as of March 5th, 2025. Mr. Herring owns 324,689 shares of Enfusion stock worth more than $3,493,654 as of March 31st. This net worth approximation does not reflect any other assets that Mr. Herring may own. Learn More about Bradley Herring's net worth.
How do I contact Bradley Herring?: The corporate mailing address for Mr. Herring and other Enfusion executives is , , . Enfusion can also be reached via phone at 312-253-9800 and via email at [email protected]. Learn More on Bradley Herring's contact information.
Has Bradley Herring been buying or selling shares of Enfusion?: Bradley Herring has not been actively trading shares of Enfusion during the past quarter. Most recently, Bradley Herring sold 4,645 shares of the business's stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $11.38, for a transaction totalling $52,860.10. Following the completion of the sale, the chief financial officer now directly owns 324,689 shares of the company's stock, valued at $3,694,960.82. Learn More on Bradley Herring's trading history.
Who are Enfusion's active insiders?: Enfusion's insider roster includes Bronwen Bastone (Chief People Officer), Matthew Campobasso (General Counsel), Dan Groman (Chief Technology Officer), Bradley Herring (CFO), Roy Luo (Director), Oleg Movchan (CEO), Neal Pawar (Chief Operating Officer), and Deirdre Somers (Director). Learn More on Enfusion's active insiders.

Bradley Herring Insider Trading History at Enfusion

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/5/2025	Sell	4,645	$11.38	$52,860.10	324,689
3/5/2025	Sell	4,645	$11.38	$52,860.10	324,689
3/3/2025	Sell	1,533	$11.48	$17,598.84	329,334
1/7/2025	Sell	4,134	$10.13	$41,877.42	266,369
12/20/2024	Sell	24,443	$10.61	$259,340.23	270,503
1/8/2024	Sell	1,998	$9.23	$18,441.54	213,690

Bradley Herring Buying and Selling Activity at Enfusion

Enfusion Company Overview

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.

Today's Range

Now: $10.76

$10.76

50 Day Range

MA: $10.85

$10.85

2 Week Range

Now: $10.76

$7.83

$11.80

Volume

N/A

Average Volume

735,304 shs

Market Capitalization

$1.39 billion

P/E Ratio

269.07

Dividend Yield